These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34755135)

  • 21. Effects of Mediterranean Diet on plasma metabolites and their relationship with insulin resistance and gut microbiota composition in a crossover randomized clinical trial.
    Galié S; García-Gavilán J; Papandreou C; Camacho-Barcía L; Arcelin P; Palau-Galindo A; Rabassa A; Bulló M
    Clin Nutr; 2021 Jun; 40(6):3798-3806. PubMed ID: 34130026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood lactate concentrations during rest and exercise in people with Multiple Sclerosis: A systematic review and meta-analysis.
    Cerexhe L; Easton C; Macdonald E; Renfrew L; Sculthorpe N
    Mult Scler Relat Disord; 2022 Jan; 57():103454. PubMed ID: 34915317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites.
    Dodd D; Spitzer MH; Van Treuren W; Merrill BD; Hryckowian AJ; Higginbottom SK; Le A; Cowan TM; Nolan GP; Fischbach MA; Sonnenburg JL
    Nature; 2017 Nov; 551(7682):648-652. PubMed ID: 29168502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood Metabolite Signature of Metabolic Syndrome Implicates Alterations in Amino Acid Metabolism: Findings from the Baltimore Longitudinal Study of Aging (BLSA) and the Tsuruoka Metabolomics Cohort Study (TMCS).
    Roberts JA; Varma VR; Huang CW; An Y; Oommen A; Tanaka T; Ferrucci L; Elango P; Takebayashi T; Harada S; Iida M; Thambisetty M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of low bone mineral density in people with multiple sclerosis: Role of physical activity.
    Cleland BT; Papanek P; Ingraham BA; Harkins A; Garnier-Villarreal M; Woo D; Csuka ME; V Ng A
    Mult Scler Relat Disord; 2020 Feb; 38():101864. PubMed ID: 31801106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut Microbial Metabolites of Aromatic Amino Acids as Signals in Host-Microbe Interplay.
    Liu Y; Hou Y; Wang G; Zheng X; Hao H
    Trends Endocrinol Metab; 2020 Nov; 31(11):818-834. PubMed ID: 32284282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomic findings in sepsis as a damage of host-microbial metabolism integration.
    Beloborodova NV; Olenin AY; Pautova AK
    J Crit Care; 2018 Feb; 43():246-255. PubMed ID: 28942199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients.
    Huang HJ; Zhang AY; Cao HC; Lu HF; Wang BH; Xie Q; Xu W; Li LJ
    Dig Liver Dis; 2013 Aug; 45(8):677-82. PubMed ID: 23384618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?
    Sestito C; Brevé JJP; van Eggermond MCJA; Killestein J; Teunissen CE; van Rossum J; Wilhelmus MMM; Drukarch B; van den Elsen PJ; van Dam AM
    J Neuroinflammation; 2017 Dec; 14(1):257. PubMed ID: 29268771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
    Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
    Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
    Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
    Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid.
    Lutz NW; Viola A; Malikova I; Confort-Gouny S; Audoin B; Ranjeva JP; Pelletier J; Cozzone PJ
    PLoS One; 2007 Jul; 2(7):e595. PubMed ID: 17611627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression.
    Lim CK; Bilgin A; Lovejoy DB; Tan V; Bustamante S; Taylor BV; Bessede A; Brew BJ; Guillemin GJ
    Sci Rep; 2017 Feb; 7():41473. PubMed ID: 28155867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.
    Xie G; Zhang S; Zheng X; Jia W
    Electrophoresis; 2013 Oct; 34(19):2787-98. PubMed ID: 23775228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
    van Doorn R; Nijland PG; Dekker N; Witte ME; Lopes-Pinheiro MA; van het Hof B; Kooij G; Reijerkerk A; Dijkstra C; van van der Valk P; van Horssen J; de Vries HE
    Acta Neuropathol; 2012 Sep; 124(3):397-410. PubMed ID: 22810490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways.
    Rachakonda V; Gabbert C; Raina A; Bell LN; Cooper S; Malik S; Behari J
    PLoS One; 2014; 9(12):e113860. PubMed ID: 25461442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolomics data exploration guided by prior knowledge.
    van den Berg RA; Rubingh CM; Westerhuis JA; van der Werf MJ; Smilde AK
    Anal Chim Acta; 2009 Oct; 651(2):173-81. PubMed ID: 19782808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
    Grobelny A; Behrens JR; Mertens S; Otte K; Mansow-Model S; Krüger T; Gusho E; Bellmann-Strobl J; Paul F; Brandt AU; Schmitz-Hübsch T
    PLoS One; 2017; 12(12):e0189281. PubMed ID: 29244874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
    Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS.
    Wuolikainen A; Moritz T; Marklund SL; Antti H; Andersen PM
    PLoS One; 2011 Apr; 6(4):e17947. PubMed ID: 21483737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.